Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
he use of implantable cardioverter-defibrillators (ICDs) has been a major advancement in patients with ischemic cardiomyopathy with reduced ejection fraction <35%. 1 Although the data supporting the use of ICDs are robust in patients with ischemic cardiomyopathy, limited randomized controlled clinical trial (RCT) data exist for similar benefit in patients with nonischemic cardiomyopathy (NICM). 2 A prior metaanalysis that included both primary and secondary prevention ICD trials in 2004 by Desai et al 2 demonstrated a 31% reduction in all-cause mortality with ICD use in patients with NICM.The data became the back bone of the current American College of Cardiology/ American Heart Association guidelines for ICD implantation in patients with NICM. 3 However, recently, the DANISH trial (Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure), which randomly assigned >1100 patients with NICM on optimal medical therapy (OMT) and cardiac resynchronization therapy (CRT) to ICD versus no ICD for primary prevention of sudden cardiac death, revealed no difference in all-cause mortality between the 2 groups at 5-year follow-up.4 Although the primary results of DAN-ISH were neutral, the ICD group showed reduction in incidence of sudden cardiac death by half, and there was an interaction of survival benefit with ICD use in younger patients with NICM.In light of the recent data, we sought to update the meta-analysis of RCTs assessing the utility of ICD for primary prevention in patients with NICM.We searched the MEDLINE, PUBMED, and SCOPUS databases using the following keywords: implantable cardioverter defibrillator, ICD, cardiac resynchronization therapy, CRT, heart failure, cardiomyopathy, and randomized controlled trials from their inception to October 20, 2016.After examining 773 relevant studies, we included 6 RCTs that assessed the efficacy of ICD for primary prevention in patients with NICM.Two authors (H.G., N.B.) independently extracted data from each individual study.We calculated risk ratios/hazard ratios and 95% confidence intervals (CIs) using the available event rate data from individual trials when these measures were not reported in the individual trial.The risk measures and 95% CIs were log transformed and combined using random-effects models.Data were analyzed for heterogeneity using the I 2 statistic.We also performed a separate analysis of trials with/without CRT use to assess the differential effect of CRT on the efficacy of ICDs.Analyses were performed using Stata V14.1 statistical software.We identified 6 RCTs enrolling 2970 patients with NICM to study the efficacy of ICDs for primary prevention.Pooled analysis of the 6 RCTs (including those with CRT defibrillator) demonstrated a statistically significant 23% risk reduction in all-cause mortality in favor of ICD therapy (hazard ratio, 0.77; 95% CI, 0.64-0.91)(Figure ).In addition, when we performed separate analysis of trials that assessed ICD plus OMT versus OMT alone (after exclusion of trials that involved patients with CRT defibrillator), we found a statistically significant 24% reduction in all-cause mortality with ICD (hazard ratio, 0.76; 95% CI, 0.62-0.94).When we compared the 2 trials (COMPANION [Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure] and DANISH-CRT subgroup) with ICD plus CRT plus OMT versus CRT plus
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defibrillator implantation in patients with nonischemic systolic heart failure
Køber, L., Thune, J. J., Nielsen, J. C., Haarbo, J., Videbæk, L., Korup, E., Jensen, G., Hildebrandt, P., Steffensen, F. H., Bruun, N. E., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1608029 · Cited by 1,763
Cited by
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,854
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000549 · Cited by 724
Schultheiss, H.-P., Fairweather, D., Caforio, A. L. P., Escher, F., Hershberger, R. E., Lipshultz, S. E., Liu, P. P., Matsumori, A., Mazzanti, A., McMurray, J., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0084-1 · Cited by 720
Ezekowitz, J. A., O'Meara, E., McDonald, M. A., Abrams, H., Chan, M., Ducharme, A., Giannetti, N., Grzeslo, A., Hamilton, P. G., Heckman, G. A., et al. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.08.022 · Cited by 676
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.036 · Cited by 629
Kolk, M. Z. H., Ruipérez-Campillo, S., Allaart, C. P., Wilde, A. A. M., Knops, R. E., Narayan, S. M., Tjong, F. V. Y., DEEP RISK investigators, Raijmakers, F. D., Van Der Lingen, A.-L. C. J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-65357-x · Cited by 49
“Although early studies demonstrated survival benefit of a prophylactic ICD in patients with non-ischaemic systolic heart failure (NICM) 4–7 , there is recent concern that these patients may receive modest benefit from the ICD 2,8 .”
Background
Metadata
- Authors
- Golwala, H., Bajaj, N. S., Arora, G., & Arora, P.
- Venue
- Circulation
- Published
- 2017-01-10
- Volume
- 135
- Issue
- 2
- Pages
- 201-203
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2563541916
- Cited by
- 128
- References
- 1
- FWCI
- 15.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.